Brenda I. Anosike

Brenda I. Anosike, MD, MPH, is Director, Pediatric Antimicrobial Stewardship at Children’s Hospital at Montefiore and Assistant Professor, Pediatrics at Montefiore-Einstein. Dr. Anosike’s clinical focus is on the treatment of various infectious diseases in healthy children, adolescents and young adults as well as those with complex medical conditions and the immunocompromised. She is co-lead for the pediatric COVID-19 monoclonal antibody program, antimicrobial/diagnostic stewardship program and global health.

After completing her Bachelor of Arts in 2002 at Brown University, Dr. Anosike attended Stony Brook University School of Medicine, earning her Doctor of Medicine in 2006. She pursued postdoctoral training with a residency and internship at Brown University, Hasbro Pediatric Residency Program, completing it in 2009. From 2017 to 2020, she undertook a clinical research fellowship in pediatric infectious diseases with Boston Children’s Hospital. In 2020, she also completed her Master of Public Health in clinical effectiveness with the Harvard T. H. Chan School of Public Health.

Dr. Anosike’s research focuses on antimicrobial management of orbital cellulitis and/or subperiosteal abscesses, global health, clinical outcomes of COVID therapeutics in children, antimicrobial stewardship tools, and immunocompromised care. Her work has been shared through peer-reviewed journals, abstracts and review articles.

Dr. Anosike is board certified and is a member of several professional societies including the American Academy of Pediatrics, the Pediatric Infectious Diseases Society and the Infectious Diseases Society of North America.